SEC Form 5 · accession 0001570523-18-000020
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Dec 31, 2017
Accepted (ET)
Mar 30, 2018 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Nov 28, 2016 | P | 1,000 | $0.0619 | A | 20,800,359 | D | |
| Common stock | Nov 29, 2016 | P | 1,000 | $0.1613 | A | 20,800,359 | D | |
| Common stock | Nov 29, 2016 | P | 1,000 | $0.1628 | A | 20,800,359 | D | |
| Common stock | Nov 29, 2016 | P | 1,000 | $0.0613 | A | 20,800,359 | D | |
| Common stock | Nov 29, 2016 | P | 1,000 | $0.0628 | A | 20,800,359 | D | |
| Common stock | Nov 29, 2016 | P | 1,000 | $0.0625 | A | 20,800,359 | D | |
| Common stock | Nov 29, 2016 | P | 1,000 | $0.0629 | A | 20,800,359 | D | |
| Common stock | Dec 2, 2016 | P | 1,000 | $0.0628 | A | 20,800,359 | D | |
| Common stock | Dec 6, 2016 | P | 1,000 | $0.0589 | A | 20,800,359 | D | |
| Common stock | Dec 8, 2016 | P | 500 | $0.0749 | A | 20,800,359 | D | |
| Common stock | Dec 14, 2016 | P | 1,250 | $0.0685 | A | 20,800,359 | D | |
| Common stock | Dec 14, 2016 | P | 1,550 | $0.074 | A | 20,800,359 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This is part 16 of 16 submissions.